Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Lowered to $182 at Piper Jaffray; 'Cash of $1.9B to Launch Patisiran & Advance Pipeline'

November 17, 2017 6:49 AM
Piper Jaffray lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $182.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles